MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Home・Aandelen Lijst・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Gesloten

SectorGezondheidszorg

34.77 2.72

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

34.36

Max

34.81

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -81M
Verkoop	75K 75K
EPS	-1.22
Winstmarge	-108,422.667
Werknemers	198
EBITDA	-7.8M -81M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+57.74% upside

Dividenden
By Dow Jones
Volgende Winsten	6 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	941M 2.6B
Vorige openingsprijs	32.05
Vorige sluitingsprijs	34.77

Nieuwssentiment

By Acuity

100%

336 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

18.91 / 20.63 Steun & Weerstand

Celldex Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 apr 2026, 23:48 UTC

Belangrijke Nieuwsgebeurtenissen

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 apr 2026, 23:36 UTC

Belangrijke Nieuwsgebeurtenissen

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 apr 2026, 22:47 UTC

Belangrijke Nieuwsgebeurtenissen

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 apr 2026, 23:49 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 apr 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 apr 2026, 23:38 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 apr 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 apr 2026, 23:12 UTC

Belangrijke Nieuwsgebeurtenissen

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 apr 2026, 23:10 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 apr 2026, 23:09 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 apr 2026, 23:08 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 apr 2026, 01:00 UTC

Belangrijke Nieuwsgebeurtenissen

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 apr 2026, 22:58 UTC

Winsten

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr 2026, 21:32 UTC

Marktinformatie

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr 2026, 20:52 UTC

Winsten

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr 2026, 20:50 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 apr 2026, 20:29 UTC

Winsten

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Celldex Therapeutics Inc Prognose

Koersdoel

By TipRanks

57.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 54.5 USD 57.74%

Hoogste 90 USD

Laagste 24 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celldex Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan Celldex Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

18.91 / 20.63Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.